布托啡諾經(jīng)鼻給藥復(fù)合靜脈輸注丙泊酚在老年患者經(jīng)內(nèi)鏡逆行膽管造影術(shù)中的應(yīng)用
發(fā)布時(shí)間:2018-07-13 18:44
【摘要】:目的評(píng)價(jià)布托啡諾經(jīng)鼻給藥復(fù)合靜脈輸注丙泊酚用于老年患者十二指腸鏡逆行胰膽管造影(ERCP)術(shù)中的麻醉效果。方法選擇經(jīng)ERCP行膽總管取石術(shù)老年患者128例,年齡65~75歲,體重48~82 kg,ASA分級(jí)Ⅱ或Ⅲ級(jí),采用隨機(jī)數(shù)字表法,將其分為4組(n=32):布托啡諾經(jīng)鼻給藥組(A組)、布托啡諾經(jīng)靜脈給藥組(B組)、芬太尼經(jīng)鼻給藥組(C組)和對(duì)照組(D組)。A組和B組分別經(jīng)鼻和經(jīng)靜脈給予布托啡諾20μg/kg(生理鹽水稀釋至2 ml);C組經(jīng)鼻給予芬太尼1μg/kg(生理鹽水稀釋至2 ml);D組經(jīng)鼻給予等容量生理鹽水。10 min后靜脈注射丙泊酚1.5~2.0 mg/kg,然后以3~7 mg/(kg·h)的速率靜脈輸注丙泊酚維持麻醉,待患者睫毛反射消失后開始手術(shù)操作,術(shù)畢停止給藥。分別于復(fù)合用藥前5 min(T0)、復(fù)合用藥后5 min(T1)、10 min(T2)、15 min(T3)、30 min(T4)、60 min(T5)及清醒時(shí)(T6)觀察并記錄MAP、HR、Sp O2等生命體征的變化,并于手術(shù)開始后15min行Ramsay鎮(zhèn)靜評(píng)分及ERCP操作過程標(biāo)準(zhǔn)評(píng)分,記錄術(shù)中一過性呼吸抑制及肢動(dòng)反應(yīng)的發(fā)生情況、丙泊酚用量及術(shù)后惡心、嘔吐的發(fā)生情況。結(jié)果 Ramsay鎮(zhèn)靜評(píng)分:A、B、C 3組100%的患者為6分,鎮(zhèn)靜評(píng)分明顯優(yōu)于D組(P0.01或0.05)。ERCP操作過程評(píng)分:≤7分者A、B、C 3組多于D組,≥8分者少于D組(P0.01)。術(shù)中肢動(dòng)的發(fā)生率、丙泊酚用量及T3-5時(shí)MAP、HR值A(chǔ)組、B組、C組低于D組;A組、C組及D組T3-5時(shí)Sp O2高于B組,術(shù)中一過性呼吸抑制的發(fā)生率低于B組;術(shù)后惡心、嘔吐的發(fā)生率C組高于A、B、D 3組(P0.05)。結(jié)論布托啡諾經(jīng)鼻給藥復(fù)合靜脈輸注丙泊酚麻醉可安全、有效地應(yīng)用于老年患者ERCP術(shù)。
[Abstract]:Objective to evaluate the anesthetic effect of butorphanol combined with intravenous infusion of propofol in elderly patients with duodenal retrograde cholangiopancreatography (ERCP). Methods 128 elderly patients with choledocholithiasis underwent choledocholithotomy through ERCP, aged 65 to 75 years old, with weight of 48 ~ 82 kg / kg ASA grade 鈪,
本文編號(hào):2120393
[Abstract]:Objective to evaluate the anesthetic effect of butorphanol combined with intravenous infusion of propofol in elderly patients with duodenal retrograde cholangiopancreatography (ERCP). Methods 128 elderly patients with choledocholithiasis underwent choledocholithotomy through ERCP, aged 65 to 75 years old, with weight of 48 ~ 82 kg / kg ASA grade 鈪,
本文編號(hào):2120393
本文鏈接:http://sikaile.net/yixuelunwen/mazuiyixuelunwen/2120393.html
最近更新
教材專著